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Figure S1. Ancestral mini-haplotype of 3 families of Czech origin  
Rare variants V1, V2, V4-V7 (see table at bottom of schematic haplotype) selected within 
the PPCD4 linked region (filled blue rectangles) were genotyped in individuals from 
families C15, C23 and C26 with the same GRHL2 mutation (V3, green cross). 
Recombination event (red cross) were identified in family C15 that refined the locus and 
associated mini-haplotype. The same mini-haplotype was identified in families C23 and 
C26, with an additional recombination events, that suggests the GRHL2 mutation in these 
families arose in a common ancestor. This ancestral mini-haplotype was absent in 
affected individual II:2 from family C33, who had the same GRHL2 mutation that occurred 
de novo.  
 
 
 
 
 
Figure S2. Schematic representation of the regulatory region surrounding the three 
GRHL2 promoter mutations  
GRHL2 gene structure showing regulatory element annotations from the Ensembl 
Regulatory Build, colored by feature. Zoom-in view of the intron 1 region encompassing 
all 3 mutations showing they fall within a predicted promoter region. The image is 
extracted from Ensembl v90 using GRCh38 assembly and GENCODE v22 gene 
annotations. G>T represents c.20+544G>T, delT represents c.20+257delT, delA 
represents c.20+133delA. Mutations are annotated in accordance with the GRHL2 cDNA 
sequence (Ensembl: ENST00000251808.7). Red bar represents the regulatory region 
(2,728 bp) sequenced in unsolved PPCD patients and cloned for the luciferase assay. 
 
 
 
 
 
 
 
 
Figure S3. Promoter features at the positions of the three intron 1 GRHL2 mutations  
Zoomed-in view of promoter features for each of the 3 mutation positions within intron 1 
of GRHL2. PCHi-C data from 4 cell types (A549 - epithelial lung carcinoma; H1ES - 
human embryonic stem cells; NHDF-AD - adult dermal fibroblasts; NHEK - normal human 
epidermal keratinocytes), and chromatin features based on ChromHMM segmentations 
of BLUEPRINT histone modification data are shown. PCHi-C data displays features such 
as DNase1 or CTCF binding sites. ChromHMM histone states for: H3 lysine 4 
trimethylation (H3K4me3), H3 lysine4monomethylation (H3K4me1), H3 lysine 36 
trimethylation (H3K36me3) for actively transcribed regions are shown. H3 lysine 9 
acetylation is associated with promoter regions. The image is based on Ensembl v90 
using GRCh38 assembly. Mutations are annotated in accordance with the GRHL2 cDNA 
sequence (Ensembl: ENST00000251808.7). Brightness of colors (red and green, brighter 
= stronger) and numbers in boxes represent scores of relative strength of features. 
 
 
 
 
 
 
 
 
 
 
Figure S4. Expression of GRHL2 in different layers of the human cornea 
(A) Interrogation of RNA-seq data derived from adult and fetal human corneal endothelial 
samples revealed no evidence of GRHL2 expression. COL8A2 is highly expressed in 
corneal endothelium. GRHL2 is expressed only in the corneal epithelium and not 
expressed in stroma. (B) RT-PCR of corneal tissue and cell types indicates GRHL2 is 
expressed in full thickness cornea, human corneal epithelial cells (HCE-s), human limbal 
epithelial cells (HLEC). No expression was detected in cultured endothelial cells (CE and 
B4G12) or stromal cells (SF). NTC = no template control. 
 
 
 
 
 
 
 
Table S1. In silico predictions of the consequence of GRHL2 variants on 
transcription factor binding 
AliBaba1 2.1 predicts transcription factor binding sites in an unknown DNA sequence 
utilizing the TRANSFAC public database. MatInspector2 utilizes a large library of matrix 
descriptions for transcription factor binding sites to locate matches in DNA sequences. 
*RKPM values also encompass flanking transcripts. All 3 mutations were predicted to 
alter transcription factor binding (loss and gain). 
 
Transcription 
factor 
C15, C23, 
C26, C33 
c.20+544G>T 
B4 
c.20+257delT 
B5 
c.20+133delA 
Expression in 
endothelium (RKPM) 
Adult Fetal 
SP1 Site lost1   12.52 17.53 
NRF1* 4 sites lost2   9.31 12.78 
ESRRA* Site gained2   41.52 8.74 
GLIS1 Site gained2   42.75 3.19 
AHR Site lost2   32.84 28.87 
MYC Site lost2   25.00 5.98 
E2F2 Site lost2   0.07 1.44 
E2F3 Site gained2   0.17 0.02 
EBF1  Site lost2  0.05 5.98 
POZ/zinc finger 
proteins Site lost
2 Site gained2  N/A N/A 
STAT6  Site gained2  27.53 21.94 
ZNF354C   Site lost2 3.53 5.61 
GLI3   Site gained2 20.15 14.68 
ZBTB7A   Site gained2 17.91 7.01 
 
 
 
 
 
 
 
 
 
 
